Latest Breaking News On - Label expansion - Page 2 : comparemela.com

ECOR: 1Q:21 Results

ECOR: 1Q:21 Results
msn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from msn.com Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomRegion flamandeBritish islesUnited kingdom generalJ neurogastroenterol motilJohn vandermostenMaoh milneMatthew whittyStephen chapmanVeterans health administration headache centerCore incNational health serviceNational institute for health research surgical medtechInnovation researchScottish health technology group

iShares NASDAQ Biotechnology Index Fund (NASDAQ:IBB), ABIOMED, Inc (NASDAQ:ABMD) - The Daily Biotech Pulse: Clinical Setback For Adverum, Galera Posts Data Readout, Moderna To Invest In Vaccine Manufacturing, Decision Day For Ardelyx

ShockWave Medical, Inc. (NASDAQ: SWAV) Verastem, Inc. (NASDAQ: VSTM) Down In The Dumps Akoya Biosciences, Inc. (NASDAQ: AKYA) Decibel Therapeutics, Inc. (NASDAQ: DBTX) IRadimed Corporation (NASDAQ: IRMD) Lucira Health, Inc. (NASDAQ: LHDX) Mesoblast Limited (NASDAQ: MESO) Protara Therapeutics, Inc. (NASDAQ: TARA) PTC Therapeutics, Inc. (NASDAQ: PTCT) Stocks In Focus Adverum Shares Sink On Serious Adverse Event Adverum Biotechnologies, Inc. (NASDAQ: ADVM) announced a suspected unexpected serious adverse reaction of hypotony, which is clinically relevant decrease in ocular pressure, in its INFINITY clinical trial evaluating ADVM-022 gene therapy for the treatment of diabetic macular edema. This event occurred 30 weeks after randomization in one patient treated with a single intravitreal injection of the high dose of ADVM-022 who has developed hypotony, with panuveitis and loss of vision in the treated eye.

United statesAuburn hillsDominican republicProtalix bioAxonics incJabil incAmerican society of gene cell therapyArdelyx incBiogen incNuvasive incTherapeutics incCelcuity incModerna incMimedx group incGalera therapeutics incMacrogenics inc